A director at Swedbank AB bought 167,000 shares at 248.878SEK and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
The Q1 result was solid, with ROE above 15%, NII holding up better than feared and solid cost control. We are puzzled by the relatively mild NII decline so far since rate cuts began circa a year ago, but find it increasingly likely that it will be less dramatic than we previously thought. Still, we find the NII outlook as rather uncertain, see downside risk to consensus revenues, and expect the ROE to fall below 15% next quarter. We reiterate our HOLD, but have raised our 2025–2027e EPS by 3–6% ...
Cost-efficiency measures (staffing down 7% YOY) are continuing to yield returns, leading SHB to a relatively mild 50bp decline in its ROE to c13% in Q1, helping the bank to close in on peers. The SEK5.00 DPS accrual in Q1 suggests SHB is on track for another generous annual payout of SEK13.50 (c11% dividend yield). We have raised our 2025–2027e EPS by 4-7% and our target price to SEK140 (125), and reiterate our BUY.
Macro headwinds and rising costs are continuing to put pressure on SEB’s profitability. Although the top line was supported by strong Markets-related income and resilient fees in Q1, the net interest margin continued to decline and the ROE fell sharply to 13.4% (down 4.2%-points YOY). Given our expectation of ROE remaining close to 13% in 2025-2026, we see limited upside from the premium price/book of 1.3x. We reiterate our HOLD but have raised our target price to SEK149 (143).
Nordea’s Q1 was a robust quarter, with a resilient >15% ROE on a strong capital position (200bp management buffer) underpinning Nordea’s widening ROE lead versus its peers. We have raised our 2025–2027e EPS by 3–4% and our target price to SEK155 (148). Nordea is trading at a c15% P/E discount to its Swedish large bank peers, which we find unjustified given its superior ROE versus the peer group. We reiterate our BUY.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.